Slide 1: Full Year Results 2021
Full Year Results 2021 Media and Investor Conference February 9, 2022 Delivering Growth – in Asia and Beyond. Page 1
Slide 2: Agenda
Agenda 1. Highlights Full-Year 2021 2. Business Units Review 3. Financial Update 4. Outlook Page 2
Slide 3: DKSH ‒ Continued Value Creation for Stakeholders
DKSH ‒ Continued Value Creation for Stakeholders Delivering growth and value creation in Asia and beyond. Page 3
Slide 4: FY 2021 – All Key Figures Above Last Year
FY 2021 – All Key Figures Above Last Year Net Sales EBIT2 Profit after tax3 EPS RONOC Free Cash Flow (in CHF billion) (in CHF million) (in CHF million) (in CHF) (in percent) (in CHF million) +5.4%1 +10.5% +39.6% +42.6% +170bps +24.5% 284.6 10.7 11.1 230.1 3.45 257.5 1.2 261.6 19.8% 18.1% 210.2 164.8
Slide 5: M&A an additional growth driver
M&A an additional growth driver Seven acquisitions in 2021 • Acquisitions across all four Business Units • Further consolidation of the specialty chemical distribution industry in APAC and Europe South Korea • Expansion into Australia and New Zealand - Bosung (TEC) China - RBC (PM) • Strong project
Slide 6: Continuation of Progressive Dividend Policy
Continuation of Progressive Dividend Policy +5.1% CAGR +11.0% 1 2.05 1.90 1.95 1.85 1.65 1.50 1.30 1.15 0.95 0.80 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 ¹ Proposal by the Board of Directors Page 6 Note: Ordinary dividend per share. The chart takes into account share split 1:100, effective
Slide 7: Business Unit Healthcare
Business Unit Healthcare • Results ahead of last year despite lockdowns in the third Net Sales (in CHF million) EBIT (in CHF million) quarter, COVID impact on the healthcare industry and Myanmar situation • Delivering on our purpose of “enriching people’s lives” +5.3%¹ +5.2%¹ by distributing COVID v
Slide 8: Business Unit Consumer Goods
Business Unit Consumer Goods Fast Moving Consumer Goods (FMCG) Net Sales (in CHF million) EBIT (in CHF million) • Transformation well on track • Net sales grow despite product portfolio rationalization +1.8%¹ +30.2%1,2 • Double-digit EBIT increase for the third consecutive year, 84.0 driven by gross
Slide 9: Business Unit Performance Materials
Business Unit Performance Materials • Strong double-digit net sales and EBIT growth Net Sales (in CHF million) EBIT (in CHF million) • Team delivers high-quality services for clients and customers challenged by supply chain disruptions +15.9%¹ +27.3%¹ 1,281.4 • DKSH consolidates industry in APAC and
Slide 10: Business Unit Technology
Business Unit Technology • Net sales grew organically and through the Bosung Net Sales (in CHF million) EBIT (in CHF million) acquisition in Korea • EBIT slightly behind last year as pandemic-related +13.3%¹ -2.8%¹ movement restrictions impacted the service business and resulted in product mix shift
Slide 11: GDP+ Net Sales Growth
GDP+ Net Sales Growth Net sales (in CHF million) Organic • Organic growth (4.6%) ahead of weighted GDP (3.2%) • All four Business Units growing, despite lockdowns in Q3 2021 +4.6% +0.8% -2.0% 11,106.3 10,742.2 M&A • Seven acquisitions deploying CHF 91.5 million +5.4%¹ • Sound multiples paid and marg
Slide 12: Double Digit EBIT Growth
Double Digit EBIT Growth EBIT (in CHF million) • EBIT of CHF 284.6 million corresponds to a double-digit growth in organic terms -2.4% +10.3 -9.1 +2.4% 284.6 +10.1% 283.4 257.5 • M&A is margin-accretive +12.5%¹ FY 2020 Organic M&A FX FY 2021 Sale of Share of FY 2021 Core business loss in reported •
Slide 13: Continued Strong Cash Generation
Continued Strong Cash Generation Capex / net sales (%) Free Cash Flow¹ (in CHF million) and Cash Conversion (%) 0.6% 300 261.6 0.5% 0.5% 250 210.2 0.4% 0.4% 0.4% 200 0.3% 156.7 150 139.5 140.6 0.2% 0.2% 100 50 0.0% 0 2017 2018 2019 2020 2021 2022 E 2017 2018 2019 2020 2021 Cash conversion2 65.4% 76.
Slide 14: Continued Strong Balance Sheet with Significant Leverage Potential
Continued Strong Balance Sheet with Significant Leverage Potential in CHF million FY 2020 FY 2021 Main changes 2021 vs. 2020: Cash/Liquid assets 680.8 673.7 • Net cash position higher despite increased Trade receivables 2,015.9 2,049.1 spend on M&A and higher dividend Inventories 1,151.8 1,164.4 • L
Slide 15: Additional Financial Indications
Additional Financial Indications FY 2019 FY 2020 FY 2021 FY 2022 Mid-term estimate estimate M&A Further M&A (net sales contribution) +1.8% +2.1% +0.8% +0.6%1 ambitions FX (net sales contribution) +1.8% -5.1% -2.0% -1% to -2%2 n.a. Tax rate3 25.3% (% of profit before tax) 26.1% 27.8% 27% to 29% 27% t
Slide 16: Future Prospects
Future Prospects Outlook for 2022 DKSH positioned for future value generation • EBIT growth in 2022 expected, assuming: ‒ Economic growth in Asia Pacific ‒ Exchange rates prevail for the remainder of the year ‒ Barring unforeseen events (excluding special items) • Well positioned to benefit from fav
Slide 17: Disclaimer
Disclaimer While this presentation has been prepared by DKSH with due care and based on information it reasonably believes to be accurate, complete and up-to-date on the date hereof, this presentation may be inaccurate or incomplete or contain typographical errors or information that is not up-to-da